O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)

V Rusch,K Albain,A Turrisi,S Swann,F Shepherd,Y Chen,R Livingston,G Darling,J Cox,W Sause

doi:10.1016/s0169-5002(05)80167-9

O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)

V Rusch, K Albain + Show 8 more

https://doi.org/10.1016/s0169-5002(05)80167-9

Copy DOI

Journal: Lung cancer (Amsterdam, Netherlands)	Publication Date: Jul 1, 2005
Citations: 18

#Concurrent Chemotherapy And Radiotherapy #Implications For Surgical Management + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)

Full Text